Industry Research Reports
Global Mesifurane Market Insights, Forecast to 2030
Industry: Food & Beverages
Published Date: 2024-04-28
Pages: 85 Pages
Report ld: 3118838
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Mesifurane Market Size(US$)
CAGR 2024-2030
3.4%
Market Size,2030
USD 131.7
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 107.8 million
Market Forecast in 2030(Value)
US$ 131.7 million
CAGR
3.4%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Mesifurane market is projected to grow from US$ 107.8 million in 2024 to US$ 131.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.
The US & Canada market for Mesifurane is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Mesifurane is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Mesifurane is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Mesifurane include The Good Scents Company, Shandong Yaroma Perfumery Co. Ltd., Ruiyuan Flavor Co. Ltd., Penta Manufacturing Co., Natural Advantage and United International Co. Ltd., etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Mesifurane, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Mesifurane, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Mesifurane, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Mesifurane sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Mesifurane market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Mesifurane sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including The Good Scents Company, Shandong Yaroma Perfumery Co. Ltd., Ruiyuan Flavor Co. Ltd., Penta Manufacturing Co., Natural Advantage and United International Co. Ltd., etc.
MARKET SEGMENTATION
By Company
- The Good Scents Company
- Shandong Yaroma Perfumery Co. Ltd.
- Ruiyuan Flavor Co. Ltd.
- Penta Manufacturing Co.
- Natural Advantage
- United International Co. Ltd.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Natural
- Synthetic
Segment by Application
- Food & Beverages
- Pharmaceuticals
- Animal Feed
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Mesifurane in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Mesifurane manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mesifurane sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Mesifurane Product Introduction
1.2 Market by Type
1.2.1 Global Mesifurane Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Natural
1.2.3 Synthetic
1.3 Market by Application
1.3.1 Global Mesifurane Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Food & Beverages
1.3.3 Pharmaceuticals
1.3.4 Animal Feed
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Mesifurane Sales Estimates and Forecasts 2019-2030
2.2 Global Mesifurane Revenue by Region
2.2.1 Global Mesifurane Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Mesifurane Revenue by Region (2019-2024)
2.2.3 Global Mesifurane Revenue by Region (2025-2030)
2.2.4 Global Mesifurane Revenue Market Share by Region (2019-2030)
2.3 Global Mesifurane Sales Estimates and Forecasts 2019-2030
2.4 Global Mesifurane Sales by Region
2.4.1 Global Mesifurane Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Mesifurane Sales by Region (2019-2024)
2.4.3 Global Mesifurane Sales by Region (2025-2030)
2.4.4 Global Mesifurane Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Mesifurane Sales by Manufacturers
3.1.1 Global Mesifurane Sales by Manufacturers (2019-2024)
3.1.2 Global Mesifurane Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mesifurane in 2023
3.2 Global Mesifurane Revenue by Manufacturers
3.2.1 Global Mesifurane Revenue by Manufacturers (2019-2024)
3.2.2 Global Mesifurane Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Mesifurane Revenue in 2023
3.3 Global Key Players of Mesifurane, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Mesifurane Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Mesifurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Mesifurane, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Mesifurane, Product Offered and Application
3.8 Global Key Manufacturers of Mesifurane, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Mesifurane Sales by Type
4.1.1 Global Mesifurane Historical Sales by Type (2019-2024)
4.1.2 Global Mesifurane Forecasted Sales by Type (2025-2030)
4.1.3 Global Mesifurane Sales Market Share by Type (2019-2030)
4.2 Global Mesifurane Revenue by Type
4.2.1 Global Mesifurane Historical Revenue by Type (2019-2024)
4.2.2 Global Mesifurane Forecasted Revenue by Type (2025-2030)
4.2.3 Global Mesifurane Revenue Market Share by Type (2019-2030)
4.3 Global Mesifurane Price by Type
4.3.1 Global Mesifurane Price by Type (2019-2024)
4.3.2 Global Mesifurane Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Mesifurane Sales by Application
5.1.1 Global Mesifurane Historical Sales by Application (2019-2024)
5.1.2 Global Mesifurane Forecasted Sales by Application (2025-2030)
5.1.3 Global Mesifurane Sales Market Share by Application (2019-2030)
5.2 Global Mesifurane Revenue by Application
5.2.1 Global Mesifurane Historical Revenue by Application (2019-2024)
5.2.2 Global Mesifurane Forecasted Revenue by Application (2025-2030)
5.2.3 Global Mesifurane Revenue Market Share by Application (2019-2030)
5.3 Global Mesifurane Price by Application
5.3.1 Global Mesifurane Price by Application (2019-2024)
5.3.2 Global Mesifurane Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Mesifurane Market Size by Type
6.1.1 US & Canada Mesifurane Sales by Type (2019-2030)
6.1.2 US & Canada Mesifurane Revenue by Type (2019-2030)
6.2 US & Canada Mesifurane Market Size by Application
6.2.1 US & Canada Mesifurane Sales by Application (2019-2030)
6.2.2 US & Canada Mesifurane Revenue by Application (2019-2030)
6.3 US & Canada Mesifurane Market Size by Country
6.3.1 US & Canada Mesifurane Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Mesifurane Sales by Country (2019-2030)
6.3.3 US & Canada Mesifurane Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Mesifurane Market Size by Type
7.1.1 Europe Mesifurane Sales by Type (2019-2030)
7.1.2 Europe Mesifurane Revenue by Type (2019-2030)
7.2 Europe Mesifurane Market Size by Application
7.2.1 Europe Mesifurane Sales by Application (2019-2030)
7.2.2 Europe Mesifurane Revenue by Application (2019-2030)
7.3 Europe Mesifurane Market Size by Country
7.3.1 Europe Mesifurane Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Mesifurane Sales by Country (2019-2030)
7.3.3 Europe Mesifurane Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Mesifurane Market Size
8.1.1 China Mesifurane Sales (2019-2030)
8.1.2 China Mesifurane Revenue (2019-2030)
8.2 China Mesifurane Market Size by Application
8.2.1 China Mesifurane Sales by Application (2019-2030)
8.2.2 China Mesifurane Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Mesifurane Market Size by Type
9.1.1 Asia Mesifurane Sales by Type (2019-2030)
9.1.2 Asia Mesifurane Revenue by Type (2019-2030)
9.2 Asia Mesifurane Market Size by Application
9.2.1 Asia Mesifurane Sales by Application (2019-2030)
9.2.2 Asia Mesifurane Revenue by Application (2019-2030)
9.3 Asia Mesifurane Sales by Region
9.3.1 Asia Mesifurane Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Mesifurane Revenue by Region (2019-2030)
9.3.3 Asia Mesifurane Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Mesifurane Market Size by Type
10.1.1 Middle East, Africa and Latin America Mesifurane Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Mesifurane Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Mesifurane Market Size by Application
10.2.1 Middle East, Africa and Latin America Mesifurane Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Mesifurane Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Mesifurane Sales by Country
10.3.1 Middle East, Africa and Latin America Mesifurane Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Mesifurane Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Mesifurane Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 The Good Scents Company
11.1.1 The Good Scents Company Company Information
11.1.2 The Good Scents Company Overview
11.1.3 The Good Scents Company Mesifurane Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 The Good Scents Company Mesifurane Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 The Good Scents Company Recent Developments
11.2 Shandong Yaroma Perfumery Co. Ltd.
11.2.1 Shandong Yaroma Perfumery Co. Ltd. Company Information
11.2.2 Shandong Yaroma Perfumery Co. Ltd. Overview
11.2.3 Shandong Yaroma Perfumery Co. Ltd. Mesifurane Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Shandong Yaroma Perfumery Co. Ltd. Mesifurane Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Shandong Yaroma Perfumery Co. Ltd. Recent Developments
11.3 Ruiyuan Flavor Co. Ltd.
11.3.1 Ruiyuan Flavor Co. Ltd. Company Information
11.3.2 Ruiyuan Flavor Co. Ltd. Overview
11.3.3 Ruiyuan Flavor Co. Ltd. Mesifurane Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Ruiyuan Flavor Co. Ltd. Mesifurane Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ruiyuan Flavor Co. Ltd. Recent Developments
11.4 Penta Manufacturing Co.
11.4.1 Penta Manufacturing Co. Company Information
11.4.2 Penta Manufacturing Co. Overview
11.4.3 Penta Manufacturing Co. Mesifurane Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Penta Manufacturing Co. Mesifurane Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Penta Manufacturing Co. Recent Developments
11.5 Natural Advantage
11.5.1 Natural Advantage Company Information
11.5.2 Natural Advantage Overview
11.5.3 Natural Advantage Mesifurane Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Natural Advantage Mesifurane Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Natural Advantage Recent Developments
11.6 United International Co. Ltd.
11.6.1 United International Co. Ltd. Company Information
11.6.2 United International Co. Ltd. Overview
11.6.3 United International Co. Ltd. Mesifurane Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 United International Co. Ltd. Mesifurane Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 United International Co. Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Mesifurane Industry Chain Analysis
12.2 Mesifurane Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mesifurane Production Mode & Process
12.4 Mesifurane Sales and Marketing
12.4.1 Mesifurane Sales Channels
12.4.2 Mesifurane Distributors
12.5 Mesifurane Customers
13 Market Dynamics
13.1 Mesifurane Industry Trends
13.2 Mesifurane Market Drivers
13.3 Mesifurane Market Challenges
13.4 Mesifurane Market Restraints
14 Key Findings in The Global Mesifurane Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Mesifurane Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Natural
Table 3. Major Manufacturers of Synthetic
Table 4. Global Mesifurane Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Mesifurane Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Mesifurane Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Mesifurane Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Mesifurane Revenue Market Share by Region (2019-2024)
Table 9. Global Mesifurane Revenue Market Share by Region (2025-2030)
Table 10. Global Mesifurane Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Mesifurane Sales by Region (2019-2024) & (MT)
Table 12. Global Mesifurane Sales by Region (2025-2030) & (MT)
Table 13. Global Mesifurane Sales Market Share by Region (2019-2024)
Table 14. Global Mesifurane Sales Market Share by Region (2025-2030)
Table 15. Global Mesifurane Sales by Manufacturers (2019-2024) & (MT)
Table 16. Global Mesifurane Sales Share by Manufacturers (2019-2024)
Table 17. Global Mesifurane Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Mesifurane Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Mesifurane, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Mesifurane Price by Manufacturers 2019-2024 (USD/MT)
Table 21. Global Mesifurane Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Mesifurane by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesifurane as of 2023)
Table 23. Global Key Manufacturers of Mesifurane, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Mesifurane, Product Offered and Application
Table 25. Global Key Manufacturers of Mesifurane, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Mesifurane Sales by Type (2019-2024) & (MT)
Table 28. Global Mesifurane Sales by Type (2025-2030) & (MT)
Table 29. Global Mesifurane Sales Share by Type (2019-2024)
Table 30. Global Mesifurane Sales Share by Type (2025-2030)
Table 31. Global Mesifurane Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Mesifurane Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Mesifurane Revenue Share by Type (2019-2024)
Table 34. Global Mesifurane Revenue Share by Type (2025-2030)
Table 35. Mesifurane Price by Type (2019-2024) & (USD/MT)
Table 36. Global Mesifurane Price Forecast by Type (2025-2030) & (USD/MT)
Table 37. Global Mesifurane Sales by Application (2019-2024) & (MT)
Table 38. Global Mesifurane Sales by Application (2025-2030) & (MT)
Table 39. Global Mesifurane Sales Share by Application (2019-2024)
Table 40. Global Mesifurane Sales Share by Application (2025-2030)
Table 41. Global Mesifurane Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Mesifurane Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Mesifurane Revenue Share by Application (2019-2024)
Table 44. Global Mesifurane Revenue Share by Application (2025-2030)
Table 45. Mesifurane Price by Application (2019-2024) & (USD/MT)
Table 46. Global Mesifurane Price Forecast by Application (2025-2030) & (USD/MT)
Table 47. US & Canada Mesifurane Sales by Type (2019-2024) & (MT)
Table 48. US & Canada Mesifurane Sales by Type (2025-2030) & (MT)
Table 49. US & Canada Mesifurane Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Mesifurane Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Mesifurane Sales by Application (2019-2024) & (MT)
Table 52. US & Canada Mesifurane Sales by Application (2025-2030) & (MT)
Table 53. US & Canada Mesifurane Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Mesifurane Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Mesifurane Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Mesifurane Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Mesifurane Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Mesifurane Sales by Country (2019-2024) & (MT)
Table 59. US & Canada Mesifurane Sales by Country (2025-2030) & (MT)
Table 60. Europe Mesifurane Sales by Type (2019-2024) & (MT)
Table 61. Europe Mesifurane Sales by Type (2025-2030) & (MT)
Table 62. Europe Mesifurane Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Mesifurane Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Mesifurane Sales by Application (2019-2024) & (MT)
Table 65. Europe Mesifurane Sales by Application (2025-2030) & (MT)
Table 66. Europe Mesifurane Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Mesifurane Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Mesifurane Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Mesifurane Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Mesifurane Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Mesifurane Sales by Country (2019-2024) & (MT)
Table 72. Europe Mesifurane Sales by Country (2025-2030) & (MT)
Table 73. China Mesifurane Sales by Type (2019-2024) & (MT)
Table 74. China Mesifurane Sales by Type (2025-2030) & (MT)
Table 75. China Mesifurane Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Mesifurane Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Mesifurane Sales by Application (2019-2024) & (MT)
Table 78. China Mesifurane Sales by Application (2025-2030) & (MT)
Table 79. China Mesifurane Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Mesifurane Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Mesifurane Sales by Type (2019-2024) & (MT)
Table 82. Asia Mesifurane Sales by Type (2025-2030) & (MT)
Table 83. Asia Mesifurane Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Mesifurane Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Mesifurane Sales by Application (2019-2024) & (MT)
Table 86. Asia Mesifurane Sales by Application (2025-2030) & (MT)
Table 87. Asia Mesifurane Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Mesifurane Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Mesifurane Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Mesifurane Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Mesifurane Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Mesifurane Sales by Region (2019-2024) & (MT)
Table 93. Asia Mesifurane Sales by Region (2025-2030) & (MT)
Table 94. Middle East, Africa and Latin America Mesifurane Sales by Type (2019-2024) & (MT)
Table 95. Middle East, Africa and Latin America Mesifurane Sales by Type (2025-2030) & (MT)
Table 96. Middle East, Africa and Latin America Mesifurane Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Mesifurane Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Mesifurane Sales by Application (2019-2024) & (MT)
Table 99. Middle East, Africa and Latin America Mesifurane Sales by Application (2025-2030) & (MT)
Table 100. Middle East, Africa and Latin America Mesifurane Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Mesifurane Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Mesifurane Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Mesifurane Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Mesifurane Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Mesifurane Sales by Country (2019-2024) & (MT)
Table 106. Middle East, Africa and Latin America Mesifurane Sales by Country (2025-2030) & (MT)
Table 107. The Good Scents Company Company Information
Table 108. The Good Scents Company Description and Major Businesses
Table 109. The Good Scents Company Mesifurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 110. The Good Scents Company Mesifurane Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. The Good Scents Company Recent Developments
Table 112. Shandong Yaroma Perfumery Co. Ltd. Company Information
Table 113. Shandong Yaroma Perfumery Co. Ltd. Description and Major Businesses
Table 114. Shandong Yaroma Perfumery Co. Ltd. Mesifurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 115. Shandong Yaroma Perfumery Co. Ltd. Mesifurane Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Shandong Yaroma Perfumery Co. Ltd. Recent Developments
Table 117. Ruiyuan Flavor Co. Ltd. Company Information
Table 118. Ruiyuan Flavor Co. Ltd. Description and Major Businesses
Table 119. Ruiyuan Flavor Co. Ltd. Mesifurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 120. Ruiyuan Flavor Co. Ltd. Mesifurane Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Ruiyuan Flavor Co. Ltd. Recent Developments
Table 122. Penta Manufacturing Co. Company Information
Table 123. Penta Manufacturing Co. Description and Major Businesses
Table 124. Penta Manufacturing Co. Mesifurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 125. Penta Manufacturing Co. Mesifurane Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Penta Manufacturing Co. Recent Developments
Table 127. Natural Advantage Company Information
Table 128. Natural Advantage Description and Major Businesses
Table 129. Natural Advantage Mesifurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 130. Natural Advantage Mesifurane Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Natural Advantage Recent Developments
Table 132. United International Co. Ltd. Company Information
Table 133. United International Co. Ltd. Description and Major Businesses
Table 134. United International Co. Ltd. Mesifurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 135. United International Co. Ltd. Mesifurane Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. United International Co. Ltd. Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Mesifurane Distributors List
Table 140. Mesifurane Customers List
Table 141. Mesifurane Market Trends
Table 142. Mesifurane Market Drivers
Table 143. Mesifurane Market Challenges
Table 144. Mesifurane Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Mesifurane Product Picture
Figure 2. Global Mesifurane Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Mesifurane Market Share by Type in 2023 & 2030
Figure 4. Natural Product Picture
Figure 5. Synthetic Product Picture
Figure 6. Global Mesifurane Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Mesifurane Market Share by Application in 2023 & 2030
Figure 8. Food & Beverages
Figure 9. Pharmaceuticals
Figure 10. Animal Feed
Figure 11. Others
Figure 12. Mesifurane Report Years Considered
Figure 13. Global Mesifurane Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Mesifurane Revenue 2019-2030 (US$ Million)
Figure 15. Global Mesifurane Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Mesifurane Revenue Market Share by Region (2019-2030)
Figure 17. Global Mesifurane Sales 2019-2030 ((MT)
Figure 18. Global Mesifurane Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Mesifurane Sales YoY (2019-2030) & (MT)
Figure 20. US & Canada Mesifurane Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Mesifurane Sales YoY (2019-2030) & (MT)
Figure 22. Europe Mesifurane Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Mesifurane Sales YoY (2019-2030) & (MT)
Figure 24. China Mesifurane Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Mesifurane Sales YoY (2019-2030) & (MT)
Figure 26. Asia (excluding China) Mesifurane Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Mesifurane Sales YoY (2019-2030) & (MT)
Figure 28. Middle East, Africa and Latin America Mesifurane Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Mesifurane Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Mesifurane in the World: Market Share by Mesifurane Revenue in 2023
Figure 31. Global Mesifurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Mesifurane Sales Market Share by Type (2019-2030)
Figure 33. Global Mesifurane Revenue Market Share by Type (2019-2030)
Figure 34. Global Mesifurane Sales Market Share by Application (2019-2030)
Figure 35. Global Mesifurane Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Mesifurane Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Mesifurane Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Mesifurane Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Mesifurane Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Mesifurane Revenue Share by Country (2019-2030)
Figure 41. US & Canada Mesifurane Sales Share by Country (2019-2030)
Figure 42. U.S. Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Mesifurane Sales Market Share by Type (2019-2030)
Figure 45. Europe Mesifurane Revenue Market Share by Type (2019-2030)
Figure 46. Europe Mesifurane Sales Market Share by Application (2019-2030)
Figure 47. Europe Mesifurane Revenue Market Share by Application (2019-2030)
Figure 48. Europe Mesifurane Revenue Share by Country (2019-2030)
Figure 49. Europe Mesifurane Sales Share by Country (2019-2030)
Figure 50. Germany Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 51. France Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 55. China Mesifurane Sales Market Share by Type (2019-2030)
Figure 56. China Mesifurane Revenue Market Share by Type (2019-2030)
Figure 57. China Mesifurane Sales Market Share by Application (2019-2030)
Figure 58. China Mesifurane Revenue Market Share by Application (2019-2030)
Figure 59. Asia Mesifurane Sales Market Share by Type (2019-2030)
Figure 60. Asia Mesifurane Revenue Market Share by Type (2019-2030)
Figure 61. Asia Mesifurane Sales Market Share by Application (2019-2030)
Figure 62. Asia Mesifurane Revenue Market Share by Application (2019-2030)
Figure 63. Asia Mesifurane Revenue Share by Region (2019-2030)
Figure 64. Asia Mesifurane Sales Share by Region (2019-2030)
Figure 65. Japan Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 69. India Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Mesifurane Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Mesifurane Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Mesifurane Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Mesifurane Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Mesifurane Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Mesifurane Sales Share by Country (2019-2030)
Figure 76. Brazil Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Mesifurane Revenue (2019-2030) & (US$ Million)
Figure 81. Mesifurane Value Chain
Figure 82. Mesifurane Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Mesifurane in 2024?
The global market size of Mesifurane in 2024 was 107.8 Million USD.
Which companies rank high in the global Mesifurane market?
What was the global market size of Mesifurane in 2030?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Mesifurane market size from 2024 to 2030?
Related Reports
Mesifurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mesifurane was estimated to be worth US$ 114 million in 2025 and is projected to reach US$ 144 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 134
USD 3950.00
(Single User License)
Global Mesifurane Market Research Report 2026
The global Mesifurane market was valued at US$ 114 million in 2025 and is anticipated to reach US$ 144 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 113
USD 2900.00
(Single User License)
Global Mesifurane Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mesifurane market size was US$ 111 million in 2024 and is forecast to a readjusted size of US$ 140 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 78
USD 4250.00
(Single User License)
Mesifurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mesifurane was estimated to be worth US$ 111 million in 2024 and is forecast to a readjusted size of US$ 140 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 101
USD 3950.00
(Single User License)
Global Mesifurane Market Research Report 2025
The global market for Mesifurane was valued at US$ 111 million in the year 2024 and is projected to reach a revised size of US$ 140 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published Date: 2025-02-27
Pages: 83
USD 2900.00
(Single User License)
Mesifurane - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Mesifurane was estimated to be worth US$ 101.1 million in 2023 and is forecast to a readjusted size of US$ 131.7 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030
Published Date: 2024-01-24
Pages: 98
USD 3950.00
(Single User License)
Global Mesifurane Market Research Report 2024
The global Mesifurane market was valued at US$ 101.1 million in 2023 and is anticipated to reach US$ 131.7 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 85
USD 2900.00
(Single User License)
Mesifurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mesifurane was estimated to be worth US$ 114 million in 2025 and is projected to reach US$ 144 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-07-14
Pages: 134
USD 3950.00 (Single User License)Global Mesifurane Market Research Report 2026
The global Mesifurane market was valued at US$ 114 million in 2025 and is anticipated to reach US$ 144 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-04-27
Pages: 113
USD 2900.00 (Single User License)Global Mesifurane Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mesifurane market size was US$ 111 million in 2024 and is forecast to a readjusted size of US$ 140 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 78
USD 4250.00 (Single User License)Mesifurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mesifurane was estimated to be worth US$ 111 million in 2024 and is forecast to a readjusted size of US$ 140 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 101
USD 3950.00 (Single User License)Global Mesifurane Market Research Report 2025
The global market for Mesifurane was valued at US$ 111 million in the year 2024 and is projected to reach a revised size of US$ 140 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published: 2025-02-27
Pages: 83
USD 2900.00 (Single User License)Mesifurane - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Mesifurane was estimated to be worth US$ 101.1 million in 2023 and is forecast to a readjusted size of US$ 131.7 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030
Published: 2024-01-24
Pages: 98
USD 3950.00 (Single User License)Global Mesifurane Market Research Report 2024
The global Mesifurane market was valued at US$ 101.1 million in 2023 and is anticipated to reach US$ 131.7 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 85
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now